Experimental study of nano-hydroxyapatite/recombinant human bone morphogenetic protein-2 composite artificial bone

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Bone defects pose significant clinical challenges requiring effective regenerative strategies.
• Current bone graft substitutes have limitations in promoting complete bone regeneration.
• Advanced composite materials offer promising solutions for bone defect repair.

Purpose of the Study:

• To evaluate the efficacy of nano-hydroxyapatite/recombinant human bone morphogenetic protein-2 (Nano-HA/rhBMP-2) composite artificial bone in repairing bone defects.
• To compare the regenerative potential of Nano-HA/rhBMP-2 with Nano-HA artificial bone.
• To provide preclinical evidence for the clinical application of Nano-HA/rhBMP-2 in bone defect repair.

Main Methods:

• An animal model of unilateral radius bone defect was created in 90 New Zealand white rabbits.
• Rabbits were divided into three groups: Nano-HA/rhBMP-2 repair, Nano-HA repair, and unrepaired control.
• Bone repair was assessed using gross observation, X-ray, SEM, radionuclide bone imaging, and biomechanical analysis at 4, 8, and 12 weeks post-operation.

Main Results:

• Both Nano-HA/rhBMP-2 and Nano-HA stimulated new bone formation.
• Nano-HA/rhBMP-2 demonstrated significantly enhanced new bone formation and superior bone defect repairing ability compared to Nano-HA (P <0.05).
• Histological and imaging analyses confirmed accelerated and more robust bone regeneration with the composite material.

Conclusions:

• Nano-HA/rhBMP-2 composite artificial bone exhibits significant potential for bone defect repair.
• The addition of rhBMP-2 to Nano-HA enhances osteogenic capacity and accelerates bone regeneration.
• This composite material shows promise as an ideal therapeutic option for clinical bone defect management.